{"id":"c838fcca-df27-403e-a3e7-19bac83ce4dc","kind":"news","code":"c838fcca-df27-403e-a3e7-19bac83ce4dc","name":"iRegene raises an undisclosed amount in equity financing","nameBasis":"translated-title","summary":"On 2026-07-14, according to Xiniu Data, iRegene completed equity financing for an undisclosed amount. Investors were Suzhou Xingzexingyongxinxing Medical Industrial Investment Fund Management Partnership (Limited Partnership). The company is a developer of chemically induced cell therapy drugs.","description":"","country":null,"category":null,"originalName":"睿健医药完成股权投资融资，金额金额未披露","eventDate":"2026-07-14T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:18:19.512Z","englishUpdatedAt":"2026-10-20T18:23:00.748Z","reviewedAt":"2026-10-20T18:23:00.748Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"5dfdaea5661fe5cd81204746e8be3d4da58bda7109d536b3561c84be0cd8f56c","companyId":"c6f40f74-5248-4720-8404-fd1e03022e90","foundedYear":null,"logoUrl":null,"originalText":"2026年7月14日，据烯牛数据报道，睿健医药完成股权投资融资，金额未披露。投资方为苏州杏泽兴涌新兴医疗产业投资基金管理合伙企业（有限合伙）。该公司为化学诱导细胞治疗药物研发商。","sources":[],"related":[{"id":"7da1e3f5-bd7e-439e-9e72-54642a731d74","kind":"institutions","code":"UB-I7221","name":"Suzhou Xingzexingyongxinxing Medical Industrial Investment Fund Management Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Suzhou Xingzexingyongxinxing Medical Industrial Investment Fund Management Partnership (Limited Partnership), a fund focused on industrial investment.","description":"Suzhou Xingzexingyongxinxing Medical Industrial Investment Fund Management Partnership (Limited Partnership), a fund focused on industrial investment.","country":null,"category":null,"originalName":"苏州杏泽兴涌新兴医疗产业投资基金管理合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:00:21.326Z","englishUpdatedAt":"2026-10-15T18:35:35.119Z","reviewedAt":"2026-10-15T18:35:35.119Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"2e9db392b254ed3efbf2b3ff7533df4dd6b416e41796f05e7cec645822223ca7","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/suzhou-xingzexingyongxinxing-medical-industrial-investment-fund-management-partnership-limited-partnership"},{"id":"c6f40f74-5248-4720-8404-fd1e03022e90","kind":"companies","code":"UB-C5987","name":"iRegene","nameBasis":"source-english","summary":"AI and chemically induced cell drug research and development.","description":"","country":"China","category":null,"originalName":"睿健医药","eventDate":null,"website":"https://www.iregene.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:36.154Z","reviewedAt":"2026-10-20T18:26:36.154Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"4f1558709e5410f70940856de858bdad558b4dea9749771117809729b847f483","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C5987"}],"path":"/news/c838fcca-df27-403e-a3e7-19bac83ce4dc","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"iRegene","path":"/companies/UB-C5987"}},"canonical":"https://uniquebase.ai/news/c838fcca-df27-403e-a3e7-19bac83ce4dc"}